Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,684.40
(
0.51%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
94.77
(
3.73%
)
Bitcoin
71,553.73
(
-2.72%
)
News Focus
News Focus
Post# of 20689
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 123046
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: jbog post# 10755

Sunday, 07/28/2013 10:33:42 PM

Sunday, July 28, 2013 10:33:42 PM

Post# of 20689
I previously predicted that Teva's thrice-weekly Copaxone will garner at most 15-20% of the US Copaxone market (#msg-87522151), so the UBS analyst (Marc Goodman) and I are on the same wavelength.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote